SmarterDividends
NVS

Novartis AG

NVS

Healthcare · Stock · annual payer

$155.01

Undervalued · +23% Add to Portfolio

Forward Yield

3.06%

Annual Dividend

$4.74

Payout Ratio

72%

5-Yr Growth

5.6%

Ex-Date

Mar 11, 2026

Frequency

Annual

Summary

As of July 2026, Novartis AG (NVS) yields 3.06% ($4.74 per share annually), with a blended fair-value estimate of $190.74 — +23% upside, so it screens as undervalued. Dividend safety grade: C (60/100). 3 years of dividend growth.

Is NVS a good dividend stock?

Yes, with caveats

Novartis AG (NVS) pays a annual dividend yielding 3.06% ($4.74/yr), with 3 years of growth and a dividend-safety grade of C. It's a solid income payer, but check the caveats below before buying.

Advantages

  • Strong 5.6% 5-yr dividend growth
  • 68% total price return over 5 years

Risks

  • Cut its dividend in 2019

Key Data

Dividend Yield
3.06%
Payout Ratio
72%
Annual Dividend
$4.74
5-Yr Avg Growth
5.6%
Ex-Dividend Date
Mar 11, 2026
Years of Growth
3
Frequency
annual
Beta
0.49
Market Cap
$294.6B
P/E Ratio
23.4
5-Yr Total Return
68%
52-Week Range
$112.34 – $170.46
Dividend Safety
C · 60/100
Ever Cut?
Yes (2019)
NVS ex-dividend date & scheduleNext ex-date Mar 11, 2026 · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $4.74 / yr per share

Per payment (annual)$474.00
Annual$474.00
Monthly avg$39.50